&w=3840&q=100)
PM Modi leaves for Namibia after concluding two-day visit to Brazil
Modi is on a five-nation visit, and Namibia will be his last stop.
In Brasilia, PM Modi held "productive talks" with President Lula, the Prime Minister's Office said in a post on X.
The discussions focused on diversifying trade ties, as well as expanding cooperation in clean energy, sustainable development and mitigating climate change. The leaders also agreed to deepen collaboration in defence, security, agriculture, space, semiconductors, artificial intelligence (AI) and Digital Public Infrastructure, it said.
Prime Minister Modi in a post on X also said that he held "fruitful talks with President Lula, who has always been passionate about India-Brazil friendship".
"Our talks included ways to deepen trade ties and also diversify bilateral trade. We both agree that there is immense scope for such linkages to thrive in the coming times," he said.
During the visit, India and Brazil also inked agreements to bolster cooperation in several areas.
The Prime Minister on Tuesday was also conferred with Brazil's highest civilian award, the Grand Collar of the National Order of the Southern Cross.
The honour was presented by President Lula in recognition of PM Modi's notable contributions to strengthening bilateral relations and enhancing India-Brazil cooperation across key global platforms.
On Monday, Prime Minister Modi attended the Brics summit, during which he said that nations must work together to make supply chains for critical minerals and technology secure and ensure that no country uses these resources for its own "selfish gain" or as a "weapon" against others.
Brics, consisting of Brazil, Russia, India, China and South Africa, has been expanded with five additional members: Egypt, Ethiopia, Iran, Saudi Arabia, and the UAE.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
First Post
11 minutes ago
- First Post
Tariff tracker: Can key nations strike tariff deals with the US before August 1 deadline?
US tariff negotiations have heated, as the August 1 deadline looms, with countries scrambling to avoid steep new duties. Deals with the EU, Japan and others have been struck, but talks with South Korea, India, Taiwan, Canada, Mexico and Brazil remain fraught read more A 3D-printed miniature of US President Donald Trump, EU flag and words "15% tariffs" are seen in this illustration taken July 27, 2025. File Image/Reuters US tariff talks with major trading partners have heated as countries scramble to head off sharp duty hikes before the looming August 1 deadline. Many of the tariff increases stem from a package unveiled in April, which outlined that dozens of economies would face higher levies — rising above the existing 10 per cent rate — due to their trade surpluses with the United States. The implementation date for these duties, delayed twice already, is now set for Friday, August 1. STORY CONTINUES BELOW THIS AD In recent weeks, Washington has expanded the list of nations facing these tariffs while simultaneously striking deals with several others, including the European Union, UK, Vietnam, Japan, Indonesia and the Philippines. The agreement reached with the European Union, announced Sunday, imposes a 15 per cent tariff on EU exports to the US — significantly lower than the 30 per cent US President Donald Trump had initially threatened. Where do other US trade talks stand? South Korea Seoul is racing to conclude an accord with Washington, as Tokyo's success in finalising its own deal has 'amped up the pressure for South Korea,' a government source told AFP. Local reports suggested Seoul may propose over $100 billion in investment as part of a broader deal, with likely involvement from major corporations like Samsung and Hyundai Motor. The South Korean government has not confirmed those reports. Officials have, however, detailed plans to boost cooperation in key sectors such as shipbuilding, semiconductors and batteries. National Security Advisor Wi Sung-lak told reporters the two nations were in 'the final and most crucial phase of negotiations' to prevent the 25 per cent tariff proposed by Trump. India Indian Commerce Minister Piyush Goyal told Bloomberg Television on Thursday that he remained confident his country could strike a deal with the United States to stave off Washington's 26 per cent tariff threat. Goyal revealed there were no 'sticking points' in the US-India trade relationship and noted that immigration policies — including rules regarding H-1B visas for skilled workers — had not been part of the ongoing talks. Despite his assurances, media outlets has reported that hopes for even an interim agreement before August 1 had begun to fade. STORY CONTINUES BELOW THIS AD Taiwan Taiwan's Premier Cho Jung-tai said Thursday that negotiators were 'working hard' amid concerns that a harsh tariff rate could damage the island's economy. Vice President Hsiao Bi-khim added that Taipei's team was 'working almost 24 hours a day to achieve trade balance and Taiwan's industrial interests, and even to further deepen cooperation.' Canada, Mexico Though Canada and Mexico escaped Trump's 'reciprocal' tariffs announced in April, products from both nations entering the US are still subject to a separate 25 per cent levy unless they are covered under a North American trade pact. That rate is poised to climb to 30 per cent for Mexican goods on August 1, while Canadian products are set to face a 35 per cent duty. Mexican President Claudia Sheinbaum said her government was 'doing everything' it could to stop the tariffs and expressed willingness to speak with Trump personally to secure a deal. Trump told reporters on Friday that no agreement with Canada had been reached. Brazil Brazil is bracing for what could amount to a virtual trade embargo on its planes, grains and other exports if Trump's threatened 50 per cent tariff is enacted on August 1. Despite the fact that the US runs a trade surplus with Brazil — Latin America's largest economy — the country was not initially expected to be targeted under Trump's 'reciprocal' tariff plan. Trump has made no effort to conceal the political undertones of the move, pointing to a judicial 'witch hunt' against his right-wing ally, former president Jair Bolsonaro, when announcing the tariff rate. STORY CONTINUES BELOW THIS AD The overtly political backdrop makes a last-minute resolution appear increasingly unlikely. With inputs from AFP
News18
24 minutes ago
- News18
Op Sindoor Debate: Amit Shah To Speak In Lok Sabha Tomorrow, PM Modi Likely To Speak
Last Updated: PM Modi will likely address Parliament on Operation Sindoor. Operation Sindoor Debate In Parliament: Prime Minister Narendra Modi is expected to participate in the ongoing debate over Operation Sindoor– India's retaliatory strikes on Pakistan following the ghastly Pahalgam terror attack– and address the Parliament on Tuesday evening. The Prime Minister is likely to address either house of the Parliament at around 7 pm on Tuesday. Additionally, Union Home Minister Amit Shah is also expected to lead the discussion in Lok Sabha tomorrow, while Defence Minister Rajnath Singh will open the debate in Rajya Sabha. Parliament began the three-day debate on the Pahalgam terror attack and Operation Sindoor from Monday, following a week of disruption. Both the ruling BJP-led National Democratic Alliance and the Opposition have fielded senior leaders for the discussions in Lok Sabha and Rajya Sabha. The lower house witnessed fiery exchange of words between the treasury and opposition benches over the terror attack and the India's strikes on Pakistan. Defence Minister Rajnath Singh began the debate in Lok Sabha, explaining how, through Operation Sindoor, the Indian armed forces hit nine terror targets in Pakistan and PoK and killed over 100 terrorists. He also said that the Operation was stopped because India's objective was achieved and not under pressure. 'We stopped action because our objectives were met. It is baseless and wrong that the Operation Sindoor was stopped under any pressure," Singh said as his statement was followed by uproar from the Opposition. The opposition parties came down heavily on central government over the announcement of a ceasefire after a three-day conflict between India and Pakistan by US President Donald Trump. Congress MP Gaurav Gogoi led the opposition's discussion, questioning the government over alleged security lapses. The Deputy Leader of Congress in the Lok Sabha asked Rajnath Singh why he did not mention in his speech how terrorists from Pakistan reached Pahalgam and killed 26 people. 'It is our duty to ask these questions in the interest of the nation," he added. Gogoi also said why security agencies are not able to nab the terrorists behind the Pahalgam attack. Meanwhile, BJP allies– Janata Dal (U) and Telugu Desam Party (TDP)– also came to applaud the government for the decision taken during Operation Sindoor, in which nine terror camps were targeted in Pakistan and PoK. view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Economic Times
29 minutes ago
- Economic Times
India, UK trade pact does not mandate patent term extensions or data exclusivity
Representative image The India-UK free trade agreement (FTA) does not mandate patent term extensions or data exclusivity, which are two common tools of evergreening of patents, according to a commerce ministry document. The move would protect the interests of the domestic generic drugs industry. The UK was demanding for inclusion of "data exclusivity" provision in the agreement. "The FTA does not mandate patent term extensions or data exclusivity -- two common tools of evergreening. India's patent law provisions on patentability criteria under Section 3(d) (of Indian Patent Act) remain fully protected," the ministry said. Section 3(d) of the Indian Patents Act, 1970, restricts patents for already-known drugs unless the new claims are superior in terms of efficacy, while Section 3(b) bars patents for products that are against public interest and do not demonstrate enhanced efficacy over existing products. Certain multinational firms have asked India to amend these laws, which were strongly opposed. The agreement, signed on July 24, may take about a year to come into force. Data exclusivity provides protection to the technical data generated by innovator companies to prove the usefulness of their products. In the pharmaceutical sector, drug companies generate data through expensive global clinical trials to prove the efficacy and safety of their new medicine. By gaining exclusive rights over this data, innovator companies can prevent their competitors from obtaining a marketing licence for low-cost versions during the tenure of this exclusivity. Earlier, India had also rejected a similar demand from the four-nation EFTA bloc in their free trade agreement negotiations. The European Free Trade Association (EFTA) members are Iceland, Liechtenstein, Norway, and Switzerland. The pact was signed in March 2023 and will be implemented later this year. The UK (AstraZeneca and GSK) and Switzerland (Novartis and Roche) have some of the major pharma firms of the world. India's generic drug industry is estimated about USD 25 billion, and the country exports 50 per cent of its produce. An expert said data exclusivity is beyond the provisions of the Trade Related Aspects of Intellectual Property Rights (TRIPS) agreement under the World Trade Organization (WTO). Evergreening of patent rights is a strategy allegedly adopted by the innovators having patent rights over products to renew them by bringing in some minor changes, such as adding new mixtures or formulations. It is done when their patent is about to expire. A patent on the new form gives the innovator company a 20-year monopoly on the drug. "The FTA does not require India to provide patent term extensions for regulatory delays and data exclusivity for pharmaceuticals or agrochemicals," it said, adding that this ensures that generic manufacturers can enter the market without unnecessary delay, once the patent has expired or is challenged. The agreement, it said, does not alter or dilute India's ability to refuse patents for minor modifications of known substances; and prevent frivolous or repetitive patent filings that block generics. "There is no obligation for patent linkage or automatic injunctions either-key tools used to delay generics in other jurisdictions," the ministry said.
